EAACI task force report: A consensus protocol for the basophil activation test for collaboration and external quality assurance.
EAACI task force report: A consensus protocol for the basophil activation test for collaboration and external quality assurance.
复制标题
EAACI 工作组报告:用于协作和外部质量保证的嗜碱性粒细胞激活测试的共识协议。
作者:
Pascal,M;Edelman,SM;Nopp,A;Möbs,C;Geilenkeuser,WJ;Knol,EF;Ebo,DG;Mertens,C;Shamji,MH;Santos,AF;Patil,S;Eberlein,B;Mayorga,C;Hoffmann,HJ
| 291 PASCAL et al. performance. 1, 2 Regulatory approval and clinical implementation require extensive standardization of laboratory protocols, cytometer settings, and results interpretation. 3 European national authorities require External Quality Assurance (EQA) of the performance of modern diagnostic laboratories by agencies independent of test suppliers to meet ISO 15189: 2012, 15189: 2013, and 9001: 2015. Based on an online survey among 59 responding European laboratories performing BAT in 2017 4, 5 (Online Supplement; Results of the online survey), a Task Force (TF) was launched in 2018 to create the basis for a BAT-EQA. Round Robins (RR) were organized with seven shipments of two donors each to 7–10 European centers with overnight courier service from Bonn, DE. Each sample was split into two aliquots:(i) To minimize variation, prior to shipment, blood basophils of anonymous donors were activated with 1 μL anti-FcεRI antibody/mL of blood and stabilized with 0.2 mL Transfix (Cytomark, UK) per mL of blood to stabilize activated basophils up to 24 h for staining 6;(ii) Fresh blood was included for stimulation and staining at the participating laboratory sites.TF members met after the third shipment to reach consensus on a protocol for BAT (Online Supplement; Proposed SOP for in house BAT). Data analysis started with identification of the relevant region in a scatter plot (Figure 1A), followed by identification of basophils with the relevant markers following different strategies, for instance, using low SSC and CD193 only or CD193/CD123 or CD193/CD203c (Figure 1B).